Podcasts about Biostatistics

At the Collaborative Clinical Trials meeting in Prato, Italy, Mike Grocott and co-host Mark Priestley speak with Sachin Kheterpal, University of Michigan Medical School's Associate Dean for Research Information Technology and the Robert B Sweet Professor and Kelley M. Kidwell, Chair of the Department of Anesthesiology and Professor of Biostatistics at the University of Michigan School of Public Health and Senior Associate Dean for Faculty Affairs . Kidwell explains sequential multiple assignment randomized trials (SMART) as multi-stage designs that randomize at key decision points to evaluate treatment sequences, distinguishing them from adaptive trials and addressing misconceptions about sample size. Kheterpal describes the University of Michigan–led Multi-Center Perioperative Outcomes Group (MPOG), contrasting EHR-based automated extraction and individual provider feedback with manually collected programs like NSQIP, and discussing alignment with AQI/NACOR and inspiration from UK National Audit Projects to improve documentation for future inference. They note emerging use of large language models to extract outcomes from free-text notes, discuss pragmatic trial designs including THRIVE, and emphasize the value of close statistician–clinician collaboration and scientific humility, highlighting a BMJ talk on countering misinformation. For more information on EBPOM Dingle, go here now: www.ebpom.org

In this TopMedTalk perioperative profile, host Andy Cumpstey interviews Professor Dan Sessler, Vice President for Clinical and Outcomes Research and Professor of Anesthesiology and Biostatistics at UTHealth Houston (McGovern Medical School), about his career as a perioperative trialist with over 1,000 publications. Sessler describes his scientific family background, early inspiration from clinical trials through Henry Kaplan's Hodgkin's work, and a shift from planned pediatric oncology to anesthesiology. He recounts building a research career starting with perioperative thermoregulation at UCLA and UCSF, then expanding into broad outcomes research, ultimately founding a large Department of Outcomes Research at the Cleveland Clinic and advocating for large multicenter trials. He emphasizes mentorship, philanthropy, and his current focus on reducing postoperative mortality through better ward monitoring and prevention beyond "failure to rescue." - The 2026 International Practicum on Cardiopulmonary Exercise Testing will be held at the Balmer Lawn Hotel in Brockenhurst, UK, from September 16th to 18th this year. It is organised by iPOETTS , the international perioperative testing and training society. Come and join us at this premier educational event designed for clinicians, scientists, and healthcare professionals interested in sport, exercise, and perioperative medicine. This is an International Perioperative Testing and Training Society accredited event so when you attend you can get your iPOETTS accreditation, showing that you are a practitioner who has reached a high, standardized level of competence in performing and interpreting Cardiopulmonary Exercise Testing (CPET) for patients preparing for major surgery. Go now to http://www.ebpom.org

In this episode, I talk with Ning Leng, Ph.D., Director II, Data and AI Acceleration Group, Data & Statistical Sciences at AbbVie, about the growing role of the R Consortium in the pharmaceutical industry. Ning brings extensive experience in statistics, computational genomics, open-source technology, and the adoption of R across the pharmaceutical industry. Before joining AbbVie, she spent 10 years at Roche Genentech, where she helped drive the adoption of R, cloud technologies, Git, and Shiny. We discuss how the R Consortium creates a platform for statisticians, programmers, pharmaceutical companies, and regulators to collaborate on practical challenges—and how that collaboration is changing the way we approach regulatory submissions.

Q-Bank: https://www.patreon.com/highyieldfamilymedicineIntro (0:35),Study Designs (1:47),Types of Bias (7:00),Sensitivity and Specificity (12:33),Predictive Value (14:22),Likelihood Ratio (15:38),Relative Risk vs Odds Ratio (16:44),Absolute vs Relative Risk Reduction (18:10),Number Needed to Treat and Number Needed to Harm (19:22),Incidence vs Prevalence (20:23),Attributable Risk (21:01),Intention-to-Treat (21:37),Confidence Intervals (22:38),P-values (23:47),Type I vs Type II Errors (24:41),Power (25:29),Survival Analysis and Hazard Ratio (26:17),Practice Questions (27:50)

On Louisiana Considered, we've been discussing the non-disclosure agreements, or NDAs, that have become commonplace in Gov. Jeff Landry's administration. The Gulf States Newsroom reported earlier this year that at least 50 elected officials signed NDAs with Louisiana Economic Development related to large-scale industrial projects.Yesterday on the show, we heard how some of these NDAs extend to the governor's office, and include the governor himself. Today, Gulf States Newsroom reporter Drew Hawkins joins us to break down his reporting and what these NDAs reveal about the current administration.A new study out of the Collaborative Data Analysis and Dillard University reveals that children living in areas with higher industrial pollution exposure have higher rates of learning disabilities. This comes after years of concerns for children who are raised near petrochemical facilities, specifically in the state's industrial corridor known as Cancer Alley. Alison Cohen, Assistant Professor of  Epidemiology & Biostatistics at the University of California, San Francisco, and Juliet Nussbaum, project epidemiologist from Dillard University, join us for more.__Today's episode of Louisiana Considered was hosted by Sara Henegan. Our managing producer is Alana Schreiber, and our assistant producer is Aubry Procell. Our engineer is Garrett Pittman.You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, the NPR App, and wherever you get your podcasts. Louisiana Considered wants to hear from you! Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

Cancer treatments have changed dramatically over the past decade, but have our dose-finding strategies kept pace? In this episode, I speak with Dr. Ayon Mukherjee, who leads statistical innovation in early oncology development at Eli Lilly. Together, we explore Project Optimus, the FDA initiative that is changing how we think about dose optimization in oncology. Instead of simply finding the highest dose patients can tolerate, Project Optimus encourages us to identify the dose that provides the best balance between efficacy, safety, pharmacokinetics, pharmacodynamics, and long-term tolerability. Ayon explains why the traditional maximum tolerated dose approach worked well for chemotherapy but often falls short for targeted therapies and immunotherapies. We also discuss how statisticians can help lead this transformation by designing better dose optimization studies and collaborating more effectively with clinicians, pharmacologists, and regulators.

BUFFALO, NY — June 18, 2026 — A new #research paper was #published in Volume 18 of Aging on May 26, 2026, titled “Early-life determinants of cardiometabolic outcomes and accelerated biological ageing in Colombia.” The study was led by first and corresponding author Juan Carlos Rivillas from the Department of Epidemiology and Biostatistics, MRC Centre for Environment and Health, School of Public Health, Imperial College London, United Kingdom. Experiences during childhood can shape health for decades. Adverse childhood experiences (ACEs), such as emotional abuse, domestic violence, food insecurity, poor health, and forced displacement, have long been linked to chronic disease. However, less is known about how these early-life hardships may influence biological aging itself. In this study, researchers examined whether childhood adversity is associated with cardiometabolic disease and accelerated biological aging among older adults in Colombia. The investigators analyzed data from 3,385 adults aged 60 years and older who participated in the nationally representative SABE-Colombia study. Five forms of childhood adversity experienced before age 15 were evaluated: emotional abuse, domestic violence, poor childhood health, food scarcity, and forced migration related to Colombia's armed conflict. Biological aging was estimated using the Klemera-Doubal Method for Biological Age, a biomarker-based measure that compares biological age with chronological age. Full press release - https://aging-us.net/2026/06/18/childhood-adversity-may-leave-lasting-biological-scars-decades-later/ DOI - https://doi.org/10.18632/aging.206384 Corresponding author - Juan Carlos Rivillas - j.rivillas-garcia20@imperial.ac.uk Abstract video - https://www.youtube.com/watch?v=5w6vgFzjcNQ Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206384 Keywords - aging, adverse childhood experiences, forced childhood migration, biological ageing, cardiometabolic outcomes, life course epidemiology To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

The World Health Organization defines health equity as a public health concept describing equity of access to health resources for genetic, socio-environmental, and economic determinants of health, varying according to individuals, families, and social or societal groups. Concerns about data equity have surfaced, which may result in many populations, including those in rural areas with disabilities, experiencing homelessness or living in low and middle-income regions of the world, being underrepresented in health data sets. This can lead to biased findings and suboptimal health outcomes for certain subgroups, which is the focus of this episode of Stats+Stories with guest Bhramar Mukherjee. Dr. Bhramar Mukherjee is the inaugural Senior Associate Dean of Public Health Data Science and Data Equity and the Anna M. R. Lauder Professor of Biostatistics, as well as Professor of Epidemiology and of Statistics and Data Science at Yale University. Among her many honors, she was elected to the US National Academy of Medicine in 2022.

External control arms are becoming increasingly important in drug development, but creating valid comparisons requires more than matching patient populations. In this episode, I speak with Ben Ackerman, Director of Real-World Biostatistics at GSK, about one of the most overlooked challenges in external control arm studies: endpoint bias. We discuss why differences in how outcomes are measured can influence study results, what researchers should consider when designing studies, and how the field is evolving to address these challenges. If you work with real-world evidence, causal inference, or innovative clinical trial designs, this episode offers valuable insights into improving the credibility and transparency of external control arm analyses.

In this episode of ACM ByteCast, Rashmi Mohan hosts 2025 ACM Fellow Cynthia Rudin, the Gilbert, Louis, and Edward Lehrman Distinguished Professor of Computer Science, Electrical and Computer Engineering, Statistical Science, Mathematics, and Biostatistics and Bioinformatics at Duke University, where she leads the Interpretable Machine Learning Lab. Her lab, which seeks to design predictive ML models that people can understand, focuses on areas including healthcare, criminal justice, and energy reliability. Among her honors, she has received the Squirrel Award for Artificial Intelligence from the Association for the Advancement of Artificial Intelligence (AAAI), as well as the IJCAI John McCarthy Award. Rudin was recently named an ACM Fellow for contributions to and leadership in interpretable machine learning and societal applications. In the interview, Cynthia clarifies the crucial distinction between "interpretable" and “explainable" AI and makes the argument that true interpretability is foundational to trustworthy, ethical AI. She shares her extensive field experience collaborating with Con Edison engineers on power grid maintenance, neurologists on medical diagnostics, and the Cambridge Police Department on crime series detection, countering the widespread industry myth that AI performance must be sacrificed for transparency. She describes an innovative paradigm her lab developed to solve the "interaction bottleneck" between data scientists and domain experts, leveraging "Rashomon sets" to generate millions of equally accurate models simultaneously, using human-computer interaction (HCI) tools to create visual, encyclopedia-like interfaces.

Did you know that glyphosate is the most commonly used herbicide in the world, and because of its ubiquitous use, glyphosate can be found in most of our bodies? Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Lianne Sheppard, PhD, Professor in the Departments of Environmental and Occupational Health Sciences, and Biostatistics at the University of WA-Seattle. Sheppard discusses highlights and conclusions from the Seattle Glyphosate Symposium, and the risks from long term, low-level exposure. She also discusses why EPA registration of a pesticide does not mean that the pesticide is safe. To see the pesticides (insecticides, herbicides, fungicides and rodenticides) used in your part of the country, see the USGS maps of pesticide use: https://water.usgs.gov/nawqa/pnsp/usage/maps/compound_listing.php Related Websites:   Glyphosate symposium: https://deohs.washington.edu/sgs/statement

Small islands generally did far better during the pandemic than bigger (and often richer) countries with more complex health systems. In this episode, Emily and Matt ask: what have been the longer-term effects of Covid-19 more than five years on? Have lessons have been learned for the next shock? Where can we see both improvements and things to worry about in health provision and outcomes? We welcome two global public health experts for our “Explainer”. Sophie Harman tells us why we should worry about not only the decline of multilateral health governance, but also what might be replacing it. Simon Rushton talks us through some of the longer-term effects of the pandemic on the Global South. Then, in the Big Picture, we are joined by Roannie Ng Shiu from Samoa and Aviane Auguste from St Lucia to learn why SIDS did relatively so well in the pandemic but why more prosaic health challenges – from measles to dengue and non-communicable diseases like diabetes – are of greater immediate concern. Finally, in no stupid questions, Matt and Emily ask whether small size and islandness are actually secret weapons in helping SIDS to achieve better health outcomes. LISTENER SURVEY: To help us make Small Islands, Big Picture even better, we've put together a short audience survey and would love your input. You can find the survey at this link and your feedback will help us shape future episodes, topics, and guests. If you have a moment, please fill it out: it only takes a couple of minutes would mean a lot to us. Thanks for listening and supporting the show! Featuring:Emily Wilkinson (host) | RESI Director and Principal Research Fellow at ODI GlobalMatthew Bishop (host) | RESI Director and Senior Lecturer at the University of SheffieldSophie Harman | Professor of International Politics, Queen Mary, University of LondonSimon Rushton | Professor of International Politics, University of SheffieldRoannie Ng Shiu | Director, Institute for Pacific and Global Health, University of AucklandAvianne Auguste | Assistant Professor, Epidemiology, Biostatistics and Occupational health, McGill University Resources:Programme page | Resilient and Sustainable Islands Initiative (RESI)Sophie's profile | Professor Sophie HarmanSophie's film | PiliSophie's book | Sick of it: the global fight for women's healthSimon's profile | Professor Simon RushtonSimon's award | ESRC Impact Prize: Improbable DialoguesSimon & Sophie's recent Lancet article | Global health partnerships for a post-2030 agendaRoannie's profile | Dr Roannie Ng ShiuRoannie's Lancet article | The 2024 small island developing states report of the Lancet Countdown on health and climate changeAviane's profile | Dr Aviane AugusteA public lecture by Aviane | Improving health outcomes in small islandsAn important Lancet piece | SIDS standing together on NCDs and mental health Hosted on Acast. See acast.com/privacy for more information.

In this episode, we explore the power of the 4+1 Program at NYU GPH, an accelerated pathway that allows students to earn both their undergraduate and master's degrees in just five years. We are joined by Nehanda Akili, an MS Biostatistics student, and Anthony Escamilla, an MPH Community Health Science and Practice student and pre-PA track junior, to discuss how this program provides a competitive edge for future healthcare leaders. Nehanda shares her journey from NYU Gallatin's individualized study—where she concentrated on the intersection of fascism and public health—to mastering data science and R coding. She discusses the importance of GPH's flexibility, which allowed her to balance 18-credit semesters while serving as President of the Black Women's Health Collective. Anthony, an EMT and psychology major, explains how the program allows him to bridge the gap between social theory and clinical practice. He highlights the financial benefits of the "plus one" year and how GPH's location in the NYC epicenter offers valuable opportunities for culturally competent public health intervention. From navigating the application process to utilizing the ecosystem of faculty support, Nehanda and Anthony offer a roadmap for students looking to maximize their time at NYU. This conversation highlights how the 4+1 Program turns academic ambition into real-world impact. To learn more about the NYU School of Global Public Health, and how our innovative programs are training the next generation of public health leaders, visit http://www.publichealth.nyu.edu.

Episode Overview In this episode, I speak with Anna Mosikian, a physician by training and Global Clinical Program Lead working at the intersection of clinical development and strategic marketing. Anna brings a powerful perspective on how clinical data translates into real-world value—bridging evidence generation, regulatory expectations, and commercial impact. We dive into what clinical leaders truly expect from statisticians and how statisticians can move from technical contributors to strategic partners. We explore what “good collaboration” really looks like in practice, why understanding the purpose of a study is critical, and how statisticians can elevate their impact through communication, proactiveness, and cross-functional thinking.

Can identifying the right patients and the right endpoints transform how we test new osteoarthritis treatments? On this week's episode of Joint Action, we unpack what the FNIH Biomarkers Consortium has learned so far, and how their latest phase aims to deliver biomarkers that can make disease-modifying OA drug trials smaller, faster, and more likely to succeed.Dr. Virginia Byers Kraus is a Professor of Medicine, Pathology, and Orthopaedic Surgery at Duke University School of Medicine. A rheumatologist and translational scientist, her research focuses on osteoarthritis and biomarker development as part of the international FNIH Biomarkers Consortium.Peter G. Mesenbrink, Ph.D., is Executive Director of Biostatistics at Novartis and industry co-chair of the FNIH Biomarkers Consortium. With expertise in adaptive trial design, surrogate endpoint development, and data sharing policy, he is a frequent collaborator across industry, regulatory, and academic communities.Dr. Jamie Collins is a biostatistician at Brigham and Women's Hospital and Associate Professor of Orthopaedic Surgery at Harvard Medical School. As lead statistician for the FNIH OA Biomarkers Consortium, her research focuses on strengthening osteoarthritis clinical trials through innovative trial design and prognostic enrichment.RESOURCESFNIH: Treatment Response Biomarkers for Disease Modifying Osteoarthritis Drugs (DMOADs)CONNECT WITH USNaia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

With the arrival of spring, anticipation grows for the start of horse racing in the United States. The pinnacle of success in the sport is achieved by a horse that will win each leg of the Triple Crown, which includes the Kentucky Derby, the Preakness Stakes, and the Belmont Stakes. The excitement and anticipation of these three races are also associated with pre-race bookmaking and betting as well. But just how good are the bookmakers at setting the odds of victory? Do their favorites win, or will long shots emerge victorious? That's the topic on today's episode of Stats+Stories with guest Larry Kupper. Dr. Kupper is Emeritus Alumni Distinguished Professor of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill. His research interests included the development and application of Statistical Methods for public health studies, particularly environmental, occupational, and women's health, and quantifying health risks from exposure to environmental and workplace hazards.

In this episode, I sit down with Rachael Lawrance to dive into a topic that has become absolutely central to clinical research: patient-centered outcomes. When I first started as a statistician, I knew these measures existed—but I didn't really understand how they were developed, analyzed, or used in decision-making. That has changed dramatically over the years. Today, patient-reported outcomes (PROs) and the broader framework of clinical outcome assessments (COAs) play a key role in regulatory approvals, payer decisions, and how we demonstrate treatment value. Rachael brings deep expertise from her work at Adelphi Values and shares how these endpoints are developed, validated, and applied in practice. We also discuss how statisticians can contribute more effectively by understanding the science behind these measures—not just treating them as “just another scale.”

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Shanshan Wu from the Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing, China, and Professor Yuanjie Pang from Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China, on the paper "Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts" published in paper copy in Gut in April 2026. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://bit.ly/4rRJeUI).

Usama Bilal, Associate Professor of Epidemiology and Co-Director of the Urban Health CollaborativeEpidemiology and Biostatistics, Drexel University, Philadelphia

In this episode of Plugged In to Public Health, Lauren sits down with Dr. Amy Herring, Professor of Statistical Science and Dean of Natural Sciences at Duke University, to explore how biostatistics shapes real-world public health research. From her early interest in applying math to meaningful problems to her current work across a wide range of health topics, Dr. Herring shares what it really looks like to build a career at the intersection of data and impact. The conversation highlights how statisticians collaborate with scientists and clinicians to translate complex questions into usable evidence. Dr. Herring walks through examples from her work, including global health research on sepsis in Tanzania, where differences in patient populations challenged assumptions built from studies in the United States and Europe. These experiences reveal how context, culture, and data quality all influence the conclusions we draw. This episode also touches on what makes collaboration effective, why understanding how data are collected is just as important as analyzing them, and how the field of biostatistics is evolving as data become larger and more complex. For students and early-career professionals, Dr. Herring offers practical advice on staying curious, getting involved in real-world data collection, and finding meaning in work that is not always linear. Whether you are interested in data, global health, or interdisciplinary research, this episode offers a grounded look at how biostatistics helps answer some of public health's most challenging questions. A transcript of this episode will be available here soon. Have a question for our podcast crew or an idea for an episode? You can email them at CPH-GradAmbassador@uiowa.edu You can also support Plugged in to Public Health by sharing this episode and others with your friends, colleagues, and social networks. #publichealth #healthcare #biostatistics #statisticalscience #naturalscience #dukeuniversity #datacollection #globalhealth #research #iowacity

What separates strong clinical research from misleading conclusions? Often, it comes down to study design. In this episode of the Clinical Trial Podcast, Kunal Sampat sits down with Dr. Thomas Newman, Professor of Epidemiology and Biostatistics at UCSF and co-author of Designing Clinical Research, to break down how observational studies actually work. While randomized controlled trials are often considered the gold standard, observational studies are essential in many real-world settings. But they come with challenges including bias, confounding, and misinterpretation that can lead to flawed conclusions if not handled correctly. Dr. Newman shares a practical framework to help you design better studies, interpret results more critically, and build a stronger foundation in clinical research. In this episode, you'll learn: When observational studies are more appropriate than randomized trials A practical framework for designing observational research Key threats to validity: bias, confounding, and chance How to interpret associations vs. causal effects Strategies for dealing with confounders in analysis How to approach statistics with more clarity and confidence About the guest: Dr. Thomas Newman, MD, MPH, is a Professor of Epidemiology and Biostatistics at the University of California, San Francisco. His work focuses on applying epidemiologic methods to important clinical problems in child health, including neonatal jaundice, infections in newborns, and cholesterol screening. He is widely recognized for his contributions to clinical research education and is co-author of Designing Clinical Research and Evidence-Based Diagnosis. Why this episode matters: If you want to grow in clinical research, you need more than surface-level knowledge - you need to understand how studies are designed and where they can go wrong. This episode helps you think like a clinical researcher.

In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Paola Sebastiani, Professor of Biostatistics at Tufts Clinical and Translational Science Institute. They explore what centenarians reveal about reaching 100, and why there's no single longevity gene.Paola explains that studies keep finding many small genetic effects, which makes polygenic risk scores hard to use for personal prediction. She says progress depends on bigger cohorts and new analyses that include structural DNA changes and mitochondrial DNA. She also grounds the hype: for people born in 1900, only 0.2% of men and about 1% of women reached 100.Healthspan sits at the center of the story. Paola ties exceptional aging to delayed disease, lower inflammation, and biomarker profiles that stay more youthful. She highlights diet as a realistic lever, with centenarians showing stable, balanced eating, steadier protein intake, and metabolite signals linked to vegetables and dark chocolate.  Guest-at-a-glance

In early January 2026, the U.S. Centers for Disease Control and Prevention announced changes to the childhood immunization schedules, reducing the number of vaccines recommended for children. This change led to the U.S. being an outlier in terms of required vaccines for children. One reason people express concern about vaccines is fear of adverse reactions. It may surprise many that there is a comprehensive system in place to monitor adverse outcomes, and this is the topic of this episode with guest Dr. Jeffrey Morris. Dr. Jeffrey Morris is the George S. Pepper Professor of Public Health and Preventative Medicine and Director Biostatistics Division, Department of Biostatistics, Epidemiology and Informatics at the Perelman School of Medicine University of Pennsylvania. He has been actively involved in scientific communication efforts on social media and with various media outlets. He is also a distinguished research fellow at the Annenberg Center for Public Policy.

Three hundred and thirty-two days, that was the international statistic of the year in 2020, as identified by the Royal Statistical Society. That was the length of time between scientists publishing the genetic sequence of COVID-19 on the 11th of January, and an effective vaccine being administered on the 8th of December. This vaccine was an integral part of the world's pandemic response. Vaccines aren't new. In a World Health Organization report describing the history of vaccines, Dr. Edward Jenner is credited with the world's first successful vaccine for smallpox in 1796. In the last 100 years, vaccines were developed for yellow fever, pertussis, polio, hepatitis B, measles, mumps, rubella, and more. Well, how do we know vaccines are safe and effective? Why do some people argue against using vaccines? That's the topic of this episode with guest Dr. Jeffery Morris. Dr. Jeffrey Morris is the George S. Pepper Professor of Public Health and Preventative Medicine and Director Biostatistics Division, Department of Biostatistics, Epidemiology and Informatics at the Perelman School of Medicine University of Pennsylvania. He has been actively involved in scientific communication efforts on social media and with various media outlets. He is also a distinguished research fellow at the Annenberg Center for Public Policy.

After moving through nine states, Aaron Caldwell chose Fayetteville as home—and started using his data skills to decode city finances and a key local bond. In this episode, his work on a modest South Fayetteville infill project, close collaboration with city staff, and a growing circle of locals working to make the city more resilient show what Strong Towns looks like through one resident's life. ADDITIONAL SHOW NOTES Aaron Caldwell (LinkedIn) Local Recommendations: Hammontree's Feed and Folly Maxine's Tap Room ‍Norm Van Eeden Petersman (LinkedIn) Do you know someone who would make for a great Bottom-Up Revolution guest? Let us know here.   This podcast is made possible by Strong Towns members. Thank you!

Dr. Lloyd Edwards is Professor and Chair of Biostatistics at the University of Alabama at Birmingham. Dr. Edwards has an extensive background in collaborating with researchers in a broad range of areas in biomedical research, including cardiovascular disease, cystic fibrosis, cancer, aging, pediatrics, and minority health. His primary area of applied statistical research relates to the analysis of longitudinal data. Specifically, his statistical research includes derivation of techniques for computation of power, control of Type I error, and measuring model fit in linear and generalized linear mixed models.

Rebecca Wilson, Katie Brickey, John Kolassa, Jocelyn Sendecki, Paul Faya, and Mahan Dastgiri discuss the 2025 ASA Biopharmaceutical Section Nonclinical Biostatistics Conference.

Tara Eicher is a postdoctoral research fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Eicher, J. Quackenbush, and A. Ne'eman. Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward. N Engl J Med 2026;394:313-315.

Overdiagnosis and Medical Decision Making with Dr. Kathleen KerrIn this episode of The Girl Doc Survival Guide, Dr. Kathleen Kerr, a Professor of Biostatistics at the University of Washington, discusses overdiagnosis and medical decision making. Dr. Kerr delves into how patients perceive mammogram results, the difference between overdiagnosis and overcalling, and the challenges pathologists face in diagnosing cancer. She also shares findings from her research on the influence of prior opinions on second diagnoses and the cognitive processes involved in interpreting pathology images. The discussion highlights the complexities and subjectivity in pathology diagnoses and the implications for patient care.00:00 Introduction and Guest Welcome00:33 Personal Anecdote on Mammograms01:25 Understanding Screening and Its Limitations02:24 Exploring Overdiagnosis05:59 Research on Dermatopathologists' Perceptions08:20 Second Opinions in Medical Decision Making12:26 Pathologists' Diagnostic Process15:42 Final Thoughts on Diagnostic Criteria

In this episode of The Rational Egoist, Michael Liebowitz speaks with Dr. Knut M. Wittkowski, a biostatistician and epidemiologist whose career has been grounded in data analysis, population-level disease dynamics, and research design.Dr. Wittkowski approaches the COVID pandemic not from politics or media narratives, but from statistical evidence and historical epidemiology. Drawing on decades of experience analysing infectious disease patterns, he challenges widely accepted assumptions about lockdowns, transmission dynamics, and public-health interventions. His focus throughout is on what the data actually show—rather than what policymakers, institutions, or commentators wished them to show.The discussion explores:How pandemics historically rise and fallThe difference between individual clinical outcomes and population-level effectsWhy certain interventions may have had unintended consequencesThe importance of distinguishing correlation from causation in public health policyHow fear and modelling assumptions can override empirical evidenceThis is a rigorous, analytical conversation that treats public health as a scientific discipline rather than a moral crusade—and asks hard questions about decision-making under uncertainty.About Dr. Knut M. WittkowskiDr. Knut M. Wittkowski holds a PhD in Biostatistics, with formal training in mathematical statistics and epidemiology in Germany. He served for roughly two decades as Head of Biostatistics, Epidemiology, and Research Design at Rockefeller University in New York.His work has focused on the statistical foundations of biomedical research, the interpretation of complex data sets, and the proper design of epidemiological studies. Throughout his career, Dr. Wittkowski has emphasised methodological rigour, empirical validation, and intellectual independence—particularly when scientific consensus becomes detached from data.About Michael Liebowitz – Host of The Rational EgoistMichael Liebowitz is the host of The Rational Egoist podcast, a philosopher, author, and political activist committed to the principles of reason, individualism, and rational self-interest. Deeply influenced by the philosophy of Ayn Rand, Michael uses his platform to challenge cultural dogma, expose moral contradictions, and defend the values that make human flourishing possible.His journey from a 25-year prison sentence to becoming a respected voice in the libertarian and Objectivist communities is a testament to the transformative power of philosophy. Today, Michael speaks, writes, and debates passionately in defence of individual rights and intellectual clarity.He is the co-author of two books examining the failures of the correctional system and the redemptive power of moral conviction:Down the Rabbit Hole: How the Culture of Corrections Encourages Crimehttps://www.amazon.com.au/Down-Rabbit-Hole-Corrections-Encourages/dp/197448064XView from a Cage: From Convict to Crusader for Libertyhttps://books2read.com/u/4jN6xjAbout Xenia Ioannou – Producer of The Rational EgoistXenia Ioannou is the producer of The Rational Egoist, responsible for overseeing the publishing, presentation, and promotion of each episode to ensure a consistent standard of clarity, professionalism, and intellectual rigour.She is the CEO of Alexa Real Estate, a property manager and entrepreneur, and serves on the Board of Directors of the Ayn Rand Centre Australia. Xenia also leads Capitalism and Coffee in Adelaide, creating a forum for thoughtful discussion on philosophy, culture, and independent thinking.Join Capitalism and Coffee here:https://www.meetup.com/adelaide-ayn-rand-meetup/Follow Xenia's essays on reason, independence, and purposeful living at her Substack:https://substack.com/@xeniaioannou?utm_source=user-menuBecause freedom is worth thinking about — and talking about.#TheRationalEgoist

Lawrence M. Schell is a Distinguished Professor in the Department of Anthropology and the College of Integrated Health Sciences at the University at Albany, SUNY, with a joint appointment in the Department of Epidemiology and Biostatistics. His research explores the interrelationship between biology and culture, with a particular focus on how contemporary urban environments shape human health and development. Dr. Schell's early work examined noise as a form of urban stress, investigating its effects on prenatal and postnatal growth. He later expanded his research to include pollutants such as polychlorinated biphenyls (PCBs) and lead, situating these exposures within the broader context of urban adaptation and health disparities. The study of lead exposure in Albany, NY, examined its influence on child physical and cognitive development, with attention to maternal nutrition and other factors that affect the transfer of lead from mother to fetus. In partnership with the Akwesasne Mohawk Nation he has recently completed three major projects. The first examined how PCBs that were used in manufacturing affect physical and sexual development during adolescence. His second project followed up the adolescents in project 1 to learn how exposure had influenced their transition into adulthood. The third project, also conducted with the Akwesasne community, explored how environmental pollutants may impact reproductive health and fertility among women. Through this work, Dr. Schell highlights the urban environment as a critical frontier for human adaptation, emphasizing the challenges posed by pollution, stress, and other features of modern city life while recognizing that these challenges are inequitably distributed in society. In 2004 Schell established a research center at Albany with NIH support to grow research on health disparities. Continued NIH support culminated in an endowment grant that will support the center and the development of health disparities research for many years to come. ------------------------------ Contact the Sausage of Science Podcast and the Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Co-Host Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Courtney Manthey, Guest-Co-Host, Website: holylaetoli.com/ E-mail: cpierce4@uccs.edu, Twitter: @HolyLaetoli Anahi Ruderman, SoS Co-Producer, HBA Junior Fellow, E-mail: ruderman@cenpat-conicet.gob.ar

Last week attempts at cloud seeding to reduce pollution in Delhi failed to produce any rain. We catch up with reporter Chhavi Sachdev to find out more about official's latest and controversial attempt at tacking hazardous levels of air pollution in the city. The Maldives have become the first country to ban smoking for younger generations with no one born on or after 1 January 2007 being able to buy tobacco products. Journalist Philippa Roxby comments on what this means for health.What do the public know about the cancer risks of alcohol? Dr Sanjay Shete, Professor of Biostatistics and Epidemiology at the University of Texas, explains his research comparing the real risks to public awareness.A Finnish study has found that voting behaviours in elections are strongly linked to health, suggesting it may even be a stronger determinant than education. Plus, how walking over 5,000 steps a day may slow the cognitive decline in those with preclinical Alzheimer's disease.Presenter: Claudia Hammond Producer: Katie Tomsett & Hannah RobinsImage: A commuter walks near India Gate amid heavy smog pollution on October 29, 2025 in New Delhi, India. Delhi is once again blanketed by hazardous smog following the Diwali festival, as pollution levels spike to the "very poor" and "severe" categories, with air quality indexes far exceeding safe limits. The crisis, which is driven by firecracker use, emissions, and seasonal crop residue burning has prompted emergency measures like cloud seeding. Image Credit: Ritesh Shukla/Getty Images

In this podcast, JPEN Editor-in-Chief Dr. Kenneth Christopher, interviews Carly Milliren from the Biostatistics and Research Design Center at Boston Children's Hospital. Carly Milliren is a health services researcher primarily in pediatrics with a specific focus on eating disorders. Carly Milliren is first author of the research article “Identifying enteral nutrition using administrative data in pediatrics patients with eating disorders: A development and validation study”. Business Corporate by Alex Menco | alexmenco.net Music promoted by www.free-stock-music.com Creative Commons Attribution 3.0 Unported License creativecommons.org/licenses/by/3.0/deed.en_US October 2025

This year's Nobel Prize in Physiology or Medicine has been awarded for discoveries that explain how the immune system attacks hostile infections, but not the body's own cells. We explain the science that won Japan's Shimon Sakaguchi and US researchers Mary Brunkow and Fred Ramsdell the prestigious award.How robots can help children with reading anxiety. Lauren Wright from the University of Chicago who led this research explains.A new targeted antibiotic has been found that treats Inflammatory Bowel Disease. Dr Graham Easton who is Professor of Clinical Communication Skills at Queen Mary University of London describes how it works.Missing your first mammogram appointment has as much impact on breast cancer outcomes than an inherited genetic risk according to new research. Ziyan Ma from the Department of Medical Epidemiology and Biostatistics at the Karolinska Institute tells us more.And should we reconsider how we treat blood pressure? Presenter: Claudia Hammond Producer: Katie Tomsett

In this episode, we speak with Dr. Melody Goodman, Dean of NYU's School of Global Public Health, Professor of Biostatistics and a leading research methodologist. Dean Goodman shares her inspiring journey from a career on Wall Street to finding her passion for biostatistics and her purpose at NYU, showcasing the many paths that lead to public health leadership. As a biostatistician, she discusses the power of data to create a narrative and highlights how her commitment to solving community problems directly informs her work at GPH. We delve into her unique, hands-on approach to research, focused on community engagement and ensuring equitable outcomes. The episode also highlights the exceptional student experience at NYU GPH. Dean Goodman shares her philosophy on empowering and mentoring students. Her commitment to working alongside students on projects is a powerful testament to the collaborative and supportive environment that defines an education at NYU GPH. To learn more about the NYU School of Global Public Health, and how our innovative programs are training the next generation of public health leaders, visit http://www.publichealth.nyu.edu. 

About this episode: Does acetaminophen use during pregnancy cause autism in children? In this episode: Brian Lee, who led the largest study on acetaminophen use and neurodevelopmental outcomes, walks through the study's findings—as well as the challenges of researching the causal effects of medication use during pregnancy. Then, biostatistician Elizabeth Stuart discusses how she thinks about assessing potential cause-and-effect relationships when studies have different strengths and weaknesses. Guest: Brian Lee, PhD, MHS, is a professor of epidemiology and biostatistics at the Dornsife School of Public Health at Drexel University.   Elizabeth Stuart, PhD, is Chair in the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health, where she focuses on designing and interpreting studies exploring causal effects. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability—JAMA What the evidence tells us about Tylenol, leucovorin, and autism—STAT Discovering How Environment Affects Autism—Hopkins Bloomberg Public Health Magazine Does A Really Cause B? How a Biostatistician Thinks About Causality—Public Health On Call (August 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Send us a textCreate Your Causal Inference Roadmap. Causal Inference, TMLE & SensitivityIf you're into causal inference and machine learning you probably heard about double machine learning (DML).DML is one of the most popular frameworks leveraging machine learning algorithms for causal inference, while offering good statistical properties.Yet...There's another framework that also leverages machine learning for causal inference that was created years earlier.Welcome to the world of targeted maximum likelihood estimation (TMLE).Our today's guest, Prof. Mark van der Laan (UC Berkeley) is the godfather of TMLE.In the episode, we discuss:- Similarities and differences between DML and TMLE- How to build a causal roadmap for your project- How Mark uses math to solve real-world problems- Why uncertainty quantification is so important------------------------------------------------------------------------------------------------------Video version available on the Youtube: https://youtu.be/qr5JolEAuJURecorded on Sep 16, 2025 in Berkeley, California, US.------------------------------------------------------------------------------------------------------*About The Guest*Mark van der Laan is a Professor in Biostatistics and Statistics at UC Berkeley. He's the godfather of Targeted Maximum Likelihood Estimation (TMLE), a semiparametric framework that uses machine learning to estimate causal effects or other statistical parameters from observational data, and its new incarnation Targeted Machine Learning.*About The Host*Aleksander (Alex) Molak is an independent machine learning researcher, educator, entrepreneur and a best-selling author in the area of causality (https://amzn.to/3QhsRz4 ).Connect with Alex:- Alex on the Internet: https://bit.ly/aleksander-molak*Links*Libraries- Deep LTMLE (Python): https://github.com/shirakawatoru/dltmlePapers- Dang, ..., van der Laan et al. (2023) - "A Causal Roadmap for Generating High-Quality Real-World Evidence" (https://arxiv.org/abs/2305.06850)- Gruber, ..., van der Laan (2021) - "Developing a Targeted Learning-Based Statistical AnalysisSupport the showCausal Bandits PodcastCausal AI || Causal Machine Learning || Causal Inference & DiscoveryWeb: https://causalbanditspodcast.comConnect on LinkedIn: https://www.linkedin.com/in/aleksandermolak/Join Causal Python Weekly: https://causalpython.io The Causal Book: https://amzn.to/3QhsRz4

In a time where we need hope and innovation more than ever, we asked 13 health leaders—all guests on this podcast—what they would do to reimagine health. Tune into the episode to hear what they shared (in order of appearance):David Zipper, Senior Fellow, MIT Mobility Initiative Maya Petersen, Professor of Biostatistics, Epidemiology and Computational Precision Health, UC Berkeley Kody Kinsley, Senior Policy Advisor, Johns Hopkins University (former Secretary of HHS in North Carolina)Theresa Cullen, Director of Public Health, Pima County, AZ Anne Zink, Lecturer & Senior Fellow, Yale School of Public Health (former Chief Medical Officer, AlaskaKaren DeSalvo, former Chief Health Officer, Google Palav Babaria, Chief Quality and Medical Officer, California Department of Health Care Services Jacey Cooper, President, Precision Health Strategies (former Medicaid Director in California)Pooja Mittal, Chief Health Equity Officer, Health NetNatalie Davis, Co-Founder and CEO, United States of CareSteve Downs, Co-Founder, Building H Katie Drasser, CEO, Rock HealthZoanne Clack, Executive Producer, Grey's Anatomy Connect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes.

Welcome back to Dr. M's Women and Children First podcast where we look at the world of Women and Children's Health through an anthropological lens with the humble understanding that we have a lot to learn. Today, I'm joined by Dr. Joel “Dr. Gator” Warsh, a pediatrician, author, and advocate for a whole-child approach to healthcare. Dr. Warsh earned his medical degree from Thomas Jefferson Medical College and completed his pediatric residency at Children's Hospital of Los Angeles. Along the way, he also obtained a Master's degree in Epidemiology and Biostatistics from Queen's University in Canada, giving him a strong foundation in both clinical care and population health. These educational pursuits make him uniquely suited for today's conversation on vaccines. He is the author of Between a Shot and a Hard Place. In his own words, he says: I've dedicated my career to helping families navigate complicated health topics with clarity. My book addresses vaccine questions in a calm, data-driven, and practical way, offering parents guidance that steers clear of extremes. Parents face unprecedented pressure to make the "right" choices, often without enough balanced information. He has been featured on major platforms sharing his message with more than 400,000 parents through social media. We discuss his passion for empowering families to make informed, individualized decisions, including in areas that have been challenging or even taboo to discuss. Today, we'll dive into his latest work, his perspectives on vaccines and preventative care, and how he envisions a future of pediatrics that is proactive rather than reactive. This is a conversation about rethinking the foundations of child health and it's one you won't want to miss. Enjoy, Dr. M

In this special replay episode — the top 3 most downloaded of all time — I'm again joined by Stuart McGuire as we explore The Chimp Paradox by Professor Steve Peters. This book provides a simple yet powerful model for understanding how our brain works — and how it often works against us if we're not aware of it. Whether in meetings, under pressure, or dealing with self-doubt, understanding your inner “chimp” can help you manage emotions, lead with clarity, and avoid the traps that keep so many statisticians and scientists stuck. This episode remains a favorite because it strikes at the core of how we think, react, and lead — especially in high-stakes scientific and business environments.

If you've been in a high street pharmacy or supermarket recently, chances are you'll have seen home test kits for all sorts of indications; blood sugar level, vitamin deficiencies, thyroid function, and even some forms of cancer. A new series of article in The BMJ revealing serious concerns with the reliability of these home tests, and raises questions about their regulation. Jonathan Deeks, professor of Biostatistics at the University of Birmingham, joins us to discuss what these tests are, and how his team have rated their usability. Also this week, the sad death of a child in Liverpool from measles highlights the growing outbreak in the UK - and this may be one of the first times many doctors have come across the infection. Frances Dutton, GP at the Small Heath Medical Practice reminds us how to recognise the sign of the infection.   Reading list Direct-to-consumer self-tests sold in the UK in 2023 How to recognise and manage measles

00:08 — John Feffer is Director of Foreign Policy in Focus. 00:33 — Art Reingold is the Division Head of Epidemiology and Biostatistics at the UC Berkeley School of Public Health. The post Russia's War in Ukraine; Plus, Corona Calls appeared first on KPFA.

Emily Riederer is a Data Science Senior Manager at Credit Risk Modeling Capital One. Her website can be found here: https://www.emilyriederer.com/   Follow along on Bluesky: Emily: ‪@emilyriederer.bsky.social‬ Ellie: @epiellie.bsky.social Lucy: @lucystats.bsky.social  

00:08 — Negar Mortazavi is a journalist, political commentator, and host of the Iran Podcast.  00:33 — Art Reingold is the Division Head of Epidemiology and Biostatistics at the UC Berkeley School of Public Health. The post Israel and Trump's War in Iran; Plus, Corona Calls appeared first on KPFA.

Carly Brantner is an assistant professor of Biostatistics & Bioinformatics at Duke University and Duke Clinical Research Institute. Resources from this episode: multicate: R package for estimating conditional average treatment effects across one or more studies using machine learning methods PCORnet® Front Door: Access point for potential investigators, patient groups, and other stakeholders to connect with PCORnet and get support for potential research studies Patient-Centered Outcomes Data Repository (PDOCR): De-identified data from 24 (and counting) PCORI-funded studies Follow along on Bluesky: Carly: @carlybrantner.bsky.social Ellie: @epiellie.bsky.social Lucy: @lucystats.bsky.social  

Drs. Jeffrey Jensen and Johanna Richey welcome Dr. Najwa Javed to Dean's Chat! Dr. Javed is a board certified podiatrist and founder of E'MAR Italy. She holds a Bachelor of Science in Biochemistry and Ethno-Anthropology from the University of Oklahoma and she has a Masters of Public Health in Biostatistics and Clinical Research with honors from the University of North Texas Health Science Center. This episode is sponsored by Bako Diagnostics! Dr. Javad received her Doctorate of Podiatric Medicine from the College of Podiatric medicine with Samuel Merritt University and she completed her surgical residency training program through the VA Palo Alto conjunction with Stanford university consortium. Join us, as she discusses the inspiration from experiences with her grandmother's health they got her interested in medicine.   Dr. Javed is the managing partner and CEO of Silicon Valley Podiatry Group and she's also the founder of E'MAR Italy, a luxury footwear brand built with patent pending medical technology for the modern women. Tune in, as we discuss “all things podiatric medicine” for this special entrepreneur episode!  She is part of the Female Founder Collective, a network of businesses led by women, supporting women. Her company won FAST Company's World Changing ideas Award, the Paysafe Entreprenista Pitch Competition and has been featured in several media outlets! She was recently featured as a speaker at the Synergy OPEN Silicone Valley Forum talking about “Scaling while staying private.” She is the recipient of the Philip Gardner award for excellence in podiatric medicine and she brings unique expertise as both practicing physician as well as Silicon Valley founder, and entrepreneur.  We hope you enjoy! https://najwajaved.com/ https://shopemar.shop/ https://bmef.org/ https://www.apma.org/

Dr. Cynthia Bulik is a clinical psychologist and one of the world's leading experts on eating disorders. She is the Founding Director of the University of North Carolina Center of Excellence for Eating Disorders and also the founder director of the Centre for Eating Disorders Innovation at Karolinska Institutet in Stockholm, Sweden. Dr. Bulik is Distinguished Professor of Eating Disorders in the Department of Psychiatry at UNC, Professor of Nutrition in the Gillings School of Global Public Health, and Professor of Medical Epidemiology and Biostatistics at Karolinska Institute.  Dr Bulik has received numerous awards for her pioneering work, including Lifetime Achievement Awards from the National Eating Disorders Association, the Academy for Eating Disorders, and the International Society of Psychiatric Genetics. She has written over 750 scientific papers, and several books aimed at educating the public about eating disorders.  Currently, Dr. Bulik's focus  is in the reconceptualization of eating disorders as being a metabo-psychiatric diseases. Food Junkies is keen to explore this interest in how metabolic disease plays a role in disordered eating: can this construct be the  common ground to start to understand the muddy waters  between eating disorders and food addiction?  In This Episode, You'll Learn:

In this episode Lucy and Ellie dig into a recently publicized paper, "Vaccination and Neurodevelopmental Disorders: A Study of Nine-Year-Old Children Enrolled in Medicaid", which has gained attention after being promoted by RFK Jr. as evidence that vaccines cause autism.    Ellie breaks down her Substack critique of the study. Together, she and Lucy discuss the methodological flaws and what a better version of this study might look like.   Vaccination and Neurodevelopmental Disorders: A Study of Nine-Year-Old Children Enrolled in Medicaid: https://publichealthpolicyjournal.com/vaccination-and-neurodevelopmental-disorders-a-study-of-nine-year-old-children-enrolled-in-medicaid/ RFK Jr is promoting a new study claiming "vaccines cause autism" but it doesn't add up. Literally [Ellie's substack]: https://epiellie.substack.com/p/rfk-jr-is-promoting-a-new-study-claiming   Follow along on Bluesky: Ellie: @epiellie.bsky.social Lucy: @lucystats.bsky.social  

Vincent Arel-Bundock is a professor at the Université de Montréal, where he studies comparative and international political economy. Vincent's website: https://arelbundock.com/ Vincent's book "Model to Meaning: How to Interpret Statistical Models With marginaleffects for R and Python": https://marginaleffects.com/     Follow along on Bluesky: Vincent: @vincentab.bsky.social Ellie: @epiellie.bsky.social Lucy: @lucystats.bsky.social    

My fabulous guest this week, Dr. Audrey Schnell, and I found ourselves very aligned in the discussion of her work as a trailblazer in personal development and transformation. Specifically the potential for Humanity as a whole to move into a much more abundant, prosperous, and enjoyable era and for individuals to reach their full, magnificent ability. This is a theme throughout her work, Dr. Schnell is renowned for her deep expertise, she has spent decades empowering individuals to break through their barriers and unlock their full potential. Dr. Schnell can uniquely pinpoint the hidden roots of self-sabotage and offer transformative guidance that leads to profound, lasting change. On this guest episode, Dr. Schnell speaks with us from the comfort of her amazing off-grid home in West Virginia. She shares about her experience starting out in the field of Epidemiology and Biostatistics, studying why and how people change for over 40 years. She goes on to share how she got into the coaching business and how health and wealth together are the foundation of success, what self-sabotage really is and how to get out of your own way.Bio:Dr. Schnell has an M.A. in Clinical Psychology and a Ph.D. in Epidemiology and Biostatistics.  She has been studying why and how people change for over 40 years. Audrey Schnell enables her clients to end self sabotage, stop derailing themselves, master their emotions and reach their goals. She helps people see the blind spots that are costing them money and eliminate emotional triggers so they can reach their potential, create long-term client relationships, and even turn difficult clients into success stores. She has been a featured speaker at retreats, been a valued guest on numerous industry podcasts and founded 2 successful online summits that featured over 20 top-flight experts from the world of healing and peak performance. Audrey lives off the grid on 40 Acres in rural West Virginia with her husband and dogs. Email: audrey@audreyschnellphd.comWebsite: www.audreyschnell.comFacebook: Audrey Schnell Instagram : audreyschnellphdLinktree : https://linktr.ee/audreyschnellLinkedin :Audrey Schnellhttps://audreyschnell.kartra.com/calendar/ZoomwithAudrey* Women Waken Wednesdays will be held weekly on Wednesdays at 6pm PST starting in February! This is a virtual Women's group I'm holding for my beautiful listeners. I would love for you to join! Please contact me (IG or Email) for Zoom info!Donations To Women Waken To Support The Show Are Greatly Appreciated